Abstract:Polycystic ovary Syndrome (PCOS) is one of the most popular diseases that cause menstrual dysfunction and infertility in women. Recently, the relationships between the gastrointestinal microbiome and metabolic disorders such as obesity, type 2 diabetes and PCOS have been discovered. However, the association between the gut microbiome and PCOS symptoms has not been well established. We systematically reviewed existing studies comparing gut microbial composition in PCOS and healthy volunteers to explore evidence for this association. A systematic search was carried out in PubMed, Embase, Cochrane Library, and Web of Science from inception to May 26, 2020, for all original cross-sectional, cohort, or case-control studies comparing the fecal microbiomes of patients with PCOS with microbiomes of healthy volunteers (controls). The primary outcomes were differences in specific gut microbes between patients with PCOS and controls. The search identified 256 citations; 10 studies were included. The total population study of these articles consists of 611 participants (including PCOS group and healthy controls group). Among the included 10 studies, nine studies compared α-diversity, and six studies demonstrated that α-diversity has a significant reduction in PCOS patients. Seven of them reported that there was a significant difference of β-diversity composition between healthy controls groups and PCOS patients. The most common bacterial alterations in PCOS patients included Bacteroidaceae, Coprococcus, Bacteroides, Prevotella, Lactobacillus, Parabacteroides, Escherichia/Shigella, and Faecalibacterium prausnitzii. No consensus has emerged from existing human studies of PCOS and gut microbiome concerning which bacterial taxa are most relevant to it. In this systematic review, we identified specific bacteria associated with microbiomes of patients with PCOS vs controls. Higher level of evidence is needed to determine whether these microbes are a product or cause of PCOS.

Interaction of PCOS with the Reproductive Tract and Gut Microbiome

Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review

Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health

Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota

Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review

Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review

Roles of Gut Microbiota in the Occurrence and Development of Polycystic Ovary Syndrome

Association between Polycystic Ovary Syndrome and Gut Microbiota

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects

Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype

Microbiome and PCOS: State-of-Art and Future Aspects

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Polycystic ovarian syndrome and microbiome: Implications for women’s health

Gut Microbiota As a Potential Target for Treatment of Polycystic Ovary Syndrome

Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology

Exploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects

Comparative Analysis of Lower Genital Tract Microbiome Between PCOS and Healthy Women

Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies

A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota